If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
123.00    2.50 (2.07%)
Bid:
118.00
Ask:
120.00
Spread: 2.00 (1.695%)
Market Cap: £96.52m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

3 Aug 2023 07:00

RNS Number : 0903I
Xaar PLC
03 August 2023
 

3 August 2023

 

Xaar plc

 

TRADING UPDATE

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2023.

 

TRADING

 

Continued strong trading - in line with expectations

 

· Revenue for the period anticipated to be £34.7 million (H1 2022: £36.6 million).

· Adjusted profit before tax in line with management expectations, with the impact of the successful factory re-organisation offset by the planned sale of £1.8 million of non-core IP assets.

 

Further strategic and operational progress

 

· Increasing number of customers developing products using Aquinox with product launches expected in H2 2023.

· Commercial partnership with Quantica announced on 5 July 2023 enhances the Group's position in leading the market in printing highly viscous fluids.

· Phase one of factory efficiency programme completed on time and within budget.

· Product Print Systems business ("EPS") delivered a strong performance in the period with both revenue and margin growth.

 

 

BALANCE SHEET

 

The Group remains well capitalised with a strong balance sheet and with a net cash position as at 30 June 2023 of £7.3 million (30 June 2022: £12.6 million) in line with management expectations, reflecting the previously communicated investment in inventory predominantly in H2 2022.

 

 

OUTLOOK

 

· Market conditions expected to improve further in China in H2 and coupled with increased customer product launches will increase demand for Xaar printheads.

· Our strategy to diversify across a range of market sectors means further product launches are expected in 2024 providing confidence in delivering our mid-term growth plans.

· Previous investment in inventory holding means the Group is well placed to capitalise on further commercial opportunities.

· While remaining vigilant to broader macroeconomic conditions the Board continues to expect to deliver its expectations for the full year.

 

 

John Mills, Chief Executive Officer, commented:

 

"We remain focused on the delivery of our strategy and taking advantage of the significant opportunities we have that will drive profitable growth. Our products continue to generate strong interest from customers, demonstrating our leadership in printing highly viscous fluids with all the sustainability benefits they can deliver. We have positive momentum, a growing product pipeline and look forward to continuing to accelerate our strategy and performance in H2 and into 2024."

 

 

 

Note: Adjusted profit before tax is profit before tax excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, gain on derivative financial instruments, restructuring and transaction expenses, research and development expenditure credit, fair value gain on financial assets at fair value through profit and loss, and amortisation of acquired intangible assets.

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Teneo

+44 (0) 207 353 4200

Giles Kernick

Olivia Lucas

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKBBBDBKDPFK
Date   Source Headline
3rd Oct 20164:33 pmRNSTotal Voting Rights
29th Sep 20169:25 amRNSBoard Changes
1st Sep 201610:44 amRNSTotal Voting Rights
26th Aug 201611:44 amRNSGrant of Options
24th Aug 20167:00 amRNS2016 Interim Results
1st Aug 20162:07 pmRNSTotal Voting Rights
13th Jul 20167:00 amRNSScheduled Trading Statement
12th Jul 20166:02 pmRNSHolding(s) in Company
1st Jul 201610:56 amRNSBlock listing Interim Review
1st Jul 201610:53 amRNSTotal Voting Rights
1st Jul 20169:32 amRNSNotice of Scheduled Trading Statement
1st Jul 20167:00 amRNSXAAR AQUIRES ENGINEERED PRINTING SOLUTIONS
2nd Jun 20163:00 pmRNSLAUNCH OF PRINTHEAD FAMILY & STRATEGIC PARTNERSHIP
1st Jun 20163:39 pmRNSTotal Voting Rights
19th May 20163:01 pmRNSResult of AGM - Replacement
18th May 20163:03 pmRNSResult of AGM
13th May 201610:09 amRNSGrant of Options
9th May 201612:42 pmRNSDirector Shareholding
4th May 20167:00 amRNSAppointment of Non-Executive Director
29th Apr 20169:00 amRNSTotal Voting Rights
15th Apr 20169:59 amRNSDirector/PDMR Shareholding - SIP Purchase
5th Apr 20163:17 pmRNSHolding(s) in Company
4th Apr 20161:58 pmRNSGrant of Options
1st Apr 20161:50 pmRNSHolding(s) in Company
1st Apr 20169:03 amRNSTotal Voting Rights
22nd Mar 201612:04 pmRNSXAAR LAUNCHES NEW FAMILY OF PRINTHEADS
18th Mar 201612:07 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNS2015 Full Year Results, 2020 Vision
7th Mar 201610:00 amRNSHolding(s) in Company
1st Mar 201610:13 amRNSTotal Voting Rights
1st Feb 20162:41 pmRNSTotal Voting Rights
22nd Jan 201612:02 pmRNSHolding(s) in Company
18th Jan 20166:16 pmRNSHolding(s) in Company
13th Jan 20167:00 amRNSScheduled Trading Statement
6th Jan 20167:00 amRNSXAAR STRENGTHENS ITS 3D PRINTING BUSINESS
4th Jan 20164:12 pmRNSBlocklisting Interim Review
4th Jan 20163:27 pmRNSTotal Voting Rights
17th Dec 201510:07 amRNSDirector Shareholding
11th Dec 20157:00 amRNSBoard Changes
9th Dec 20154:56 pmRNSHolding(s) in Company
1st Dec 20155:52 pmRNSTotal Voting Rights
25th Nov 20153:46 pmRNSHolding(s) in Company
16th Nov 20159:50 amRNSHolding(s) in Company
9th Nov 20151:53 pmRNSDirector/PDMR Shareholding
4th Nov 20157:00 amRNSInterim Management Statement
2nd Nov 20152:43 pmRNSTotal Voting Rights
7th Oct 20157:00 amRNSNotice of Trading Statement
1st Oct 201510:42 amRNSTotal Voting Rights
1st Sep 20152:43 pmRNSTotal Voting Rights
28th Aug 20153:44 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.